raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:424107

Congenital myopathy with myasthenic-like onset

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy, Neonatal
Status
active

Congenital myopathy with myasthenic-like onset is a rare, genetic, non-dystrophic myopathy characterized by fatigable muscle weakness associated with congenital myopathy. Patients present with axial hypotonia, myopathic facies with fatigable ptosis, feeding difficulties, delayed gross motor development and proximal limb weakness with a RYR1-related typical pattern of muscle involvement (i.e. severe involvement of the soleus muscle and sparring of the rectus femoris, sartorius, gracilis and semitendinous muscles). Scoliosis and frequent respiratory tract infections are additional observed features.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCongenital myopathy with myasthenic-like onset
frMyopathie congénitale à début pseudo-myasthénique
deKongenitale Myopathie mit Myasthenie-ähnlichem Beginn
esMiopatía congénita con inicio similar al miasténico
itMiopatia congenita a esordio simil-miastenico
nlCongenitale myopathie met myasthenie-achtige aanvang
ptMiopatia congénita com início semelhante à miastenia
plMiopatia wrodzona o początku podobnym do miastenii
csVrozená myopatie s nástupem podobným myastenii
ukВроджена міопатія з міастенічним початком
zh先天性肌病伴肌无力样发作
trMiyastenik benzeri başlangıç ile seyreden doğumsal miyopati

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10G71.2NTBTattributedvalidated
MONDO0018528Evalidated
UMLSC4706390Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
RYR1Disease-causing germline mutation(s) inAssessedHGNC:10483ENSG0000019621818090119q13.2ryanodine receptor 124951453[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families2 casesWorldwideCase(s)Validated24951453[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_24951453[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

25 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0003473Fatigable weakness
Frequent (79-30%)
HP:0001284Areflexia
HP:0008936Axial hypotonia
HP:0003458EMG: myopathic abnormalities
HP:0003388Easy fatigability
HP:0001508Failure to thrive
HP:0011968Feeding difficulties
HP:0001288Gait disturbance
HP:0002047Malignant hyperthermia
HP:0003789Minicore myopathy
HP:0001270Motor delay
HP:0002828Multiple joint contractures
HP:0002058Myopathic facies
HP:0003198Myopathy
HP:0003701Proximal muscle weakness
HP:0000508Ptosis
HP:0002205Recurrent respiratory infections
HP:0003691Scapular winging
HP:0002650Scoliosis
HP:0003803Type 1 muscle fiber predominance
Very rare (<4-1%)
HP:0000602Ophthalmoplegia
HP:0002747Respiratory insufficiency due to muscle weakness
Excluded (0%)
HP:0003236Elevated circulating creatine kinase concentration
HP:0040191Rectus femoris muscle atrophy
HP:0003201Rhabdomyolysis

Run the differential on the 1 obligate / very frequent terms

Annotation source: 24951453[PMID]_21482111[PMID]_29556213[PMID]

7

Sources for this card